|
|
|
Volumn 33, Issue 7, 2009, Pages 26-32
|
|
Manufacturers face new risk-managements requirements
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
14BETA BROMOACETAMIDOMORPHINE;
3 METHYLTHIOFENTANYL;
4 OXOISOTRETINOIN;
5 METHYLOXYMORPHONE;
ACETYLMETHADOL;
ALOSETRON;
CLOZAPINE;
HYDROMORPHONE;
IBUPROFEN PLUS OXYCODONE;
MIFEPRISTONE;
OPIATE;
POMALIDOMIDE;
DRUG ABUSE;
DRUG INDUSTRY;
DRUG LEGISLATION;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG MISUSE;
DRUG RESEARCH;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
PRESCRIPTION;
RISK MANAGEMENT;
SHORT SURVEY;
|
|
EID: 70350210545
PISSN: 15432521
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (2)
|
|
References (0)
|
